Venturelab
close

Brain oxygen monitoring in high-risk preterm infants.

OxyPrem AG

Swiss Startup - OxyPrem Profile Main Image
Incorporated
20.09.2018
Headquarters
Zürich
Support

Preterm children are among the most vulnerable patients in modern clinical care. Their bodies are underdeveloped and they are in an extremely fragile condition. A very important role is played by the oxygen supply to the brain: When there is an under- or even oversupply of oxygen, these children face the threat of life-long damages or immediate death. Worst of all, this can not be observed from the outside, which is a terrible situation for the medical staff and for the parents, let alone for the babies themselves. OxyPrem is a new sensor which uses harmless light to show the oxygen situation in the preterm brain. It gets placed onto the head of the baby and notifies doctors when oxygen levels move outside the normal range. Then, easy and effective countermeasures can be taken.

Milestones news

14.11.2025

MDR CE mark submission

06.06.2024

Design Freeze for new sensor

01.08.2022

OxyPrem now ISO 13485 certified

01.08.2022

OxyPrem in Swiss Excellence Award finals

01.01.2022

OxyPrem obtains CHF 2.2 million grant

01.11.2020

OxyPrem wins another Seal of Excellence

01.05.2020

OxyPrem wins EU Seal of Excellence

01.09.2019

OxyPrem 1.4 gets CE mark

01.09.2019

OxyPrem obtains EU support

01.08.2019

OxyPrem wins Venture Kick

01.05.2019

OxyPrem enters Innosuisse Core Coaching

01.04.2019

OxyPrem wins Swiss Indian AIT award

01.02.2019

OxyPrem enters Wyss Zurich

01.12.2018

Uniscientia supports UZH and OxyPrem

01.11.2018

OxyPrem moves on in Venture Kick

01.08.2018

OxyPrem gets venture kicked

01.02.2018

OxyPrem team obtains UZH BioEntrepreneur Fellowship

01.02.2018

Cooperation with Therapy Development Accelerator

Show all
Swiss Startup - OxyPrem Product Image Swiss Startup - OxyPrem Team Image Swiss Startup - OxyPrem Additional Image